
Authors of a study conclude that the use of managed care organizations for Medicaid patients has a mixed record of success, and they advise that little may be achieved by converting this portion of the population to managed care.

Authors of a study conclude that the use of managed care organizations for Medicaid patients has a mixed record of success, and they advise that little may be achieved by converting this portion of the population to managed care.

Healthcare integrated with housing support for homeless medically vulnerable lowers costs without affecting quality of care.

As physicians and researchers question whether certain treatments for early signs of breast cancer are necessary, the first large US study will seek to determine the best way to manage ductal carcinoma in situ.

The latest Kaiser Family Foundation tracking survey of registered voters finds the ACA is only one of many issues considered in the choice of who they vote for.

For HIV-positive patients, cost considerations take on added importance because of the expensive antiretroviral prescription medications. As such, assessing premiums alone may not provide an accurate measure of plan affordability for HIV-positive patients.

Study finds new opioid use high among adults with COPD, raising safety concerns in this vulnerable population.

Data from 2 large studies of patients with metastatic disease who underwent myelosuppressive chemotherapy found that febrile neutropenia occurred in approximately 13% to 21% of patients. Associated costs of febrile neutropenia were found to range from $16,000 to $19,000 per episode for most hospitalized patients.

While the costs of private Medicare Advantage plans are slightly less, on average, than traditional Medicare, broad determinations can be misleading, a new report finds.

Contrary to popular perceptions that healthcare financing in the US is predominantly private, Americans pay the world’s highest health-related taxes, study finds.

Biopharmaceutical and diagnostic companies from around the world have come together to call for improved incentives to develop antibiotics that fight superbugs.

Republican Congressional Committee members question MACPAC leadership’s conflicts of interest.

A new Blue Cross Blue Shield Association report provides the company’s snapshot of US health insurance trends.

Researchers created a new tool that can measure patient satisfaction with comprehensive pharmacy programs.

High deductibles do not ensure that enrollees price shop for their healthcare more than traditional plan enrollees do.

A program for homebound patients reduces spending and improves care in high-risk older Medicare beneficiaries.

An individualized comprehensive care package for acute exacerbation of chronic obstructive pulmonary disease patients reduces 90-day mortality.

Palliative care initiated in the emergency department for patients with advanced cancer improves quality of life without shortening survival.

Two new studies highlight different approaches to cut sugar intake through soda for children and adults in an attempt to reduce overweight and obesity.

Healthcare coverage among parents has increased, but many remain unable to afford coverage.

Cost sharing for marketplace plans remained essentially unchanged from 2014 to 2015, but stable premiums during the period do not reflect the greater costs borne by enrollees, according to a report from The Commonwealth Fund.

The largest US hospitals are hardly using hospital-based mobile apps, and are thus missing opportunities to engage patients.

Both patients and hospitals in states that expanded Medicaid benefited from the wider eligibility.

Diet and exercise improve exercise ability for patients with common type of heart failure.

Researchers examine the policy of taxing unhealthy foods and drinks in order to reduce rates of obesity, diabetes, hypertension, and other conditions linked to poor eating habits.

ACA marketplace consumer protections for 2016 will strengthen health plan network transparency and make it faster to get nonformulary drugs.

Drugs targeting genetic mutations that drive tumor growth have revolutionized treatment for some serious forms of cancer, but the tumors usually become resistant to the drugs’ therapeutic effects and resume growth.

Patients with cancer who have paid sick leave are almost twice as likely to retain their jobs.

Hospital employment of physicians and ownership of physician practices is associated with higher prices and spending for outpatient care in the commercial healthcare market.

How well postmenopausal patients tolerate tamoxifen and anastrozole for one type of breast cancer varies with age.

New data does not support the idea that aspirin has protective qualities and “down-the-road” benefits for breast cancer patients. It may, however, help reduce breast density and improve earlier detection of some breast cancers.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
